“…Approximately 2-4 % of chordomas are benign. Since they respond poorly to irradiation and chemotherapy, extensive resection is desirable but often impossible because of the extent of the tumor at presentation and because of several anatomical constraints [1,2,3,4,5,6]. The recurrence rates are high and the prognosis is poor with few patients surviving longer than 5 years [5,7].…”